IBDEI1HG ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23989,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23989,1,3,0)
;;=3^Transsexualism
;;^UTILITY(U,$J,358.3,23989,1,4,0)
;;=4^F64.0
;;^UTILITY(U,$J,358.3,23989,2)
;;=^121404
;;^UTILITY(U,$J,358.3,23990,0)
;;=B35.1^^82^1041^59
;;^UTILITY(U,$J,358.3,23990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23990,1,3,0)
;;=3^Tinea Unguium
;;^UTILITY(U,$J,358.3,23990,1,4,0)
;;=4^B35.1
;;^UTILITY(U,$J,358.3,23990,2)
;;=^119748
;;^UTILITY(U,$J,358.3,23991,0)
;;=L03.90^^82^1041^3
;;^UTILITY(U,$J,358.3,23991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23991,1,3,0)
;;=3^Cellulitis,Unspec
;;^UTILITY(U,$J,358.3,23991,1,4,0)
;;=4^L03.90
;;^UTILITY(U,$J,358.3,23991,2)
;;=^5009067
;;^UTILITY(U,$J,358.3,23992,0)
;;=L03.91^^82^1041^7
;;^UTILITY(U,$J,358.3,23992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23992,1,3,0)
;;=3^Lymphangitis,Acute,Unspec
;;^UTILITY(U,$J,358.3,23992,1,4,0)
;;=4^L03.91
;;^UTILITY(U,$J,358.3,23992,2)
;;=^5009068
;;^UTILITY(U,$J,358.3,23993,0)
;;=L25.9^^82^1041^4
;;^UTILITY(U,$J,358.3,23993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23993,1,3,0)
;;=3^Contact Dermatitis,Unspec Cause
;;^UTILITY(U,$J,358.3,23993,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,23993,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,23994,0)
;;=L40.0^^82^1041^54
;;^UTILITY(U,$J,358.3,23994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23994,1,3,0)
;;=3^Psoriasis Vulgaris
;;^UTILITY(U,$J,358.3,23994,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,23994,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,23995,0)
;;=L40.2^^82^1041^1
;;^UTILITY(U,$J,358.3,23995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23995,1,3,0)
;;=3^Acrodermatitis Continua
;;^UTILITY(U,$J,358.3,23995,1,4,0)
;;=4^L40.2
;;^UTILITY(U,$J,358.3,23995,2)
;;=^5009162
;;^UTILITY(U,$J,358.3,23996,0)
;;=L40.3^^82^1041^57
;;^UTILITY(U,$J,358.3,23996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23996,1,3,0)
;;=3^Pustulosis Palmaris et Plantaris
;;^UTILITY(U,$J,358.3,23996,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,23996,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,23997,0)
;;=L40.4^^82^1041^5
;;^UTILITY(U,$J,358.3,23997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23997,1,3,0)
;;=3^Guttate Psoriasis
;;^UTILITY(U,$J,358.3,23997,1,4,0)
;;=4^L40.4
;;^UTILITY(U,$J,358.3,23997,2)
;;=^5009164
;;^UTILITY(U,$J,358.3,23998,0)
;;=L40.8^^82^1041^55
;;^UTILITY(U,$J,358.3,23998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23998,1,3,0)
;;=3^Psoriasis,Other
;;^UTILITY(U,$J,358.3,23998,1,4,0)
;;=4^L40.8
;;^UTILITY(U,$J,358.3,23998,2)
;;=^271917
;;^UTILITY(U,$J,358.3,23999,0)
;;=L40.9^^82^1041^56
;;^UTILITY(U,$J,358.3,23999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23999,1,3,0)
;;=3^Psoriasis,Unspec
;;^UTILITY(U,$J,358.3,23999,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,23999,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,24000,0)
;;=L57.0^^82^1041^2
;;^UTILITY(U,$J,358.3,24000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24000,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,24000,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,24000,2)
;;=^66900
;;^UTILITY(U,$J,358.3,24001,0)
;;=L97.911^^82^1041^33
;;^UTILITY(U,$J,358.3,24001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24001,1,3,0)
;;=3^Non-Prs Chr Ulc,RLL,Ltd to Brkdwn Skin
;;^UTILITY(U,$J,358.3,24001,1,4,0)
;;=4^L97.911
;;^UTILITY(U,$J,358.3,24001,2)
;;=^5133679
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1HG 3749 printed Sep 23, 2025@19:44:48 Page 2
IBDEI1HG ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23989,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,23989,1,3,0)
+4 ;;=3^Transsexualism
+5 ;;^UTILITY(U,$J,358.3,23989,1,4,0)
+6 ;;=4^F64.0
+7 ;;^UTILITY(U,$J,358.3,23989,2)
+8 ;;=^121404
+9 ;;^UTILITY(U,$J,358.3,23990,0)
+10 ;;=B35.1^^82^1041^59
+11 ;;^UTILITY(U,$J,358.3,23990,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,23990,1,3,0)
+14 ;;=3^Tinea Unguium
+15 ;;^UTILITY(U,$J,358.3,23990,1,4,0)
+16 ;;=4^B35.1
+17 ;;^UTILITY(U,$J,358.3,23990,2)
+18 ;;=^119748
+19 ;;^UTILITY(U,$J,358.3,23991,0)
+20 ;;=L03.90^^82^1041^3
+21 ;;^UTILITY(U,$J,358.3,23991,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,23991,1,3,0)
+24 ;;=3^Cellulitis,Unspec
+25 ;;^UTILITY(U,$J,358.3,23991,1,4,0)
+26 ;;=4^L03.90
+27 ;;^UTILITY(U,$J,358.3,23991,2)
+28 ;;=^5009067
+29 ;;^UTILITY(U,$J,358.3,23992,0)
+30 ;;=L03.91^^82^1041^7
+31 ;;^UTILITY(U,$J,358.3,23992,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,23992,1,3,0)
+34 ;;=3^Lymphangitis,Acute,Unspec
+35 ;;^UTILITY(U,$J,358.3,23992,1,4,0)
+36 ;;=4^L03.91
+37 ;;^UTILITY(U,$J,358.3,23992,2)
+38 ;;=^5009068
+39 ;;^UTILITY(U,$J,358.3,23993,0)
+40 ;;=L25.9^^82^1041^4
+41 ;;^UTILITY(U,$J,358.3,23993,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,23993,1,3,0)
+44 ;;=3^Contact Dermatitis,Unspec Cause
+45 ;;^UTILITY(U,$J,358.3,23993,1,4,0)
+46 ;;=4^L25.9
+47 ;;^UTILITY(U,$J,358.3,23993,2)
+48 ;;=^5133647
+49 ;;^UTILITY(U,$J,358.3,23994,0)
+50 ;;=L40.0^^82^1041^54
+51 ;;^UTILITY(U,$J,358.3,23994,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,23994,1,3,0)
+54 ;;=3^Psoriasis Vulgaris
+55 ;;^UTILITY(U,$J,358.3,23994,1,4,0)
+56 ;;=4^L40.0
+57 ;;^UTILITY(U,$J,358.3,23994,2)
+58 ;;=^5009160
+59 ;;^UTILITY(U,$J,358.3,23995,0)
+60 ;;=L40.2^^82^1041^1
+61 ;;^UTILITY(U,$J,358.3,23995,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,23995,1,3,0)
+64 ;;=3^Acrodermatitis Continua
+65 ;;^UTILITY(U,$J,358.3,23995,1,4,0)
+66 ;;=4^L40.2
+67 ;;^UTILITY(U,$J,358.3,23995,2)
+68 ;;=^5009162
+69 ;;^UTILITY(U,$J,358.3,23996,0)
+70 ;;=L40.3^^82^1041^57
+71 ;;^UTILITY(U,$J,358.3,23996,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,23996,1,3,0)
+74 ;;=3^Pustulosis Palmaris et Plantaris
+75 ;;^UTILITY(U,$J,358.3,23996,1,4,0)
+76 ;;=4^L40.3
+77 ;;^UTILITY(U,$J,358.3,23996,2)
+78 ;;=^5009163
+79 ;;^UTILITY(U,$J,358.3,23997,0)
+80 ;;=L40.4^^82^1041^5
+81 ;;^UTILITY(U,$J,358.3,23997,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,23997,1,3,0)
+84 ;;=3^Guttate Psoriasis
+85 ;;^UTILITY(U,$J,358.3,23997,1,4,0)
+86 ;;=4^L40.4
+87 ;;^UTILITY(U,$J,358.3,23997,2)
+88 ;;=^5009164
+89 ;;^UTILITY(U,$J,358.3,23998,0)
+90 ;;=L40.8^^82^1041^55
+91 ;;^UTILITY(U,$J,358.3,23998,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,23998,1,3,0)
+94 ;;=3^Psoriasis,Other
+95 ;;^UTILITY(U,$J,358.3,23998,1,4,0)
+96 ;;=4^L40.8
+97 ;;^UTILITY(U,$J,358.3,23998,2)
+98 ;;=^271917
+99 ;;^UTILITY(U,$J,358.3,23999,0)
+100 ;;=L40.9^^82^1041^56
+101 ;;^UTILITY(U,$J,358.3,23999,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,23999,1,3,0)
+104 ;;=3^Psoriasis,Unspec
+105 ;;^UTILITY(U,$J,358.3,23999,1,4,0)
+106 ;;=4^L40.9
+107 ;;^UTILITY(U,$J,358.3,23999,2)
+108 ;;=^5009171
+109 ;;^UTILITY(U,$J,358.3,24000,0)
+110 ;;=L57.0^^82^1041^2
+111 ;;^UTILITY(U,$J,358.3,24000,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,24000,1,3,0)
+114 ;;=3^Actinic Keratosis
+115 ;;^UTILITY(U,$J,358.3,24000,1,4,0)
+116 ;;=4^L57.0
+117 ;;^UTILITY(U,$J,358.3,24000,2)
+118 ;;=^66900
+119 ;;^UTILITY(U,$J,358.3,24001,0)
+120 ;;=L97.911^^82^1041^33
+121 ;;^UTILITY(U,$J,358.3,24001,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,24001,1,3,0)
+124 ;;=3^Non-Prs Chr Ulc,RLL,Ltd to Brkdwn Skin
+125 ;;^UTILITY(U,$J,358.3,24001,1,4,0)
+126 ;;=4^L97.911
+127 ;;^UTILITY(U,$J,358.3,24001,2)
+128 ;;=^5133679
